(RITM) Rithm Capital - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US64828T2015
Stock:
Total Rating 31
Risk 67
Buy Signal -0.53
| Risk 5d forecast | |
|---|---|
| Volatility | 25.3% |
| Relative Tail Risk | -0.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.41 |
| Alpha | -21.24 |
| Character TTM | |
|---|---|
| Beta | 0.569 |
| Beta Downside | 0.572 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.47% |
| CAGR/Max DD | 0.74 |
EPS (Earnings per Share)
Revenue
Description: RITM Rithm Capital
Rithm Capital Corp. operates as an asset manager focused on real estate, credit, and financial services in the United States. It operates through Origination and Servicing, Residential Transitional Lending, and Asset Management and Investment Portfolio. The company's investment portfolio primarily comprises of single-family rental properties, title, appraisal and property preservation and maintenance businesses; real estate securities, call rights, SFR properties, residential mortgage loans, collateralized loan obligations and consumer loans, excess mortgage servicing rights, servicer advance investments, and asset management related investments. It also provides government-sponsored enterprise (GSE) and government guaranteed loans; non-GSE or non-government guaranteed loans; and residential transitional lending. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as New Residential Investment Corp. and changed its name to Rithm Capital Corp. in August 2022. Rithm Capital Corp. was incorporated in 2011 and is based in New York, New York.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 681.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.0 > 0.02 and ΔFCF/TA 5.03 > 1.0 |
| NWC/Revenue: -38.72% < 20% (prev -59.35%; Δ 20.63% < -1%) |
| CFO/TA 0.00 > 3% & CFO 12.5m > Net Income 681.4m |
| Net Debt (37.78b) to EBITDA (2.19b): 17.26 < 3 |
| Current Ratio: 0.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (564.7m) vs 12m ago 7.30% < -2% |
| Gross Margin: 92.15% > 18% (prev 0.94%; Δ 9121 % > 0.5%) |
| Asset Turnover: 11.20% > 50% (prev 10.57%; Δ 0.63% > 0%) |
| Interest Coverage Ratio: 1.22 > 6 (EBITDA TTM 2.19b / Interest Expense TTM 1.73b) |
Altman Z'' 0.02
| A: -0.04 (Total Current Assets 1.85b - Total Current Liabilities 4.00b) / Total Assets 53.07b |
| B: -0.00 (Retained Earnings -19.9m / Total Assets 53.07b) |
| C: 0.04 (EBIT TTM 2.12b / Avg Total Assets 49.56b) |
| D: 0.00 (Book Value of Equity 56.7m / Total Liabilities 43.81b) |
| Altman-Z'' Score: 0.02 = B |
Beneish M
| DSRI: 0.71 (Receivables 3.81b/4.72b, Revenue 5.55b/4.87b) |
| GMI: 1.02 (GM 92.15% / 93.99%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.14 (Revenue 5.55b / 4.87b) |
| TATA: 0.01 (NI 681.4m - CFO 12.5m) / TA 53.07b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of RITM shares?
As of March 04, 2026, the stock is trading at USD 9.95 with a total of 9,254,262 shares traded.
Over the past week, the price has changed by -1.97%, over one month by -9.13%, over three months by -10.86% and over the past year by -8.95%.
Over the past week, the price has changed by -1.97%, over one month by -9.13%, over three months by -10.86% and over the past year by -8.95%.
Is RITM a buy, sell or hold?
Rithm Capital has received a consensus analysts rating of 4.64.
Therefore, it is recommended to buy RITM.
- StrongBuy: 7
- Buy: 4
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RITM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.5 | 45.7% |
| Analysts Target Price | 14.5 | 45.7% |
RITM Fundamental Data Overview February 28, 2026
P/E Trailing = 10.0
P/E Forward = 5.0761
P/S = 1.5292
P/B = 0.8787
Revenue TTM = 5.55b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.19b USD
Long Term Debt = 32.36b USD (from longTermDebt, two quarters ago)
Short Term Debt = 4.00b USD (from shortTermDebt, last quarter)
Debt = 39.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 37.78b USD (from netDebt column, last quarter)
Enterprise Value = 43.56b USD (5.78b + Debt 39.62b - CCE 1.85b)
Interest Coverage Ratio = 1.22 (Ebit TTM 2.12b / Interest Expense TTM 1.73b)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 43.56b)
FCF Margin = 0.0% (FCF TTM 0.0 / Revenue TTM 5.55b)
Net Margin = 12.27% (Net Income TTM 681.4m / Revenue TTM 5.55b)
Gross Margin = 92.15% ((Revenue TTM 5.55b - Cost of Revenue TTM 435.9m) / Revenue TTM)
Gross Margin QoQ = 90.95% (prev 92.28%)
Tobins Q-Ratio = 0.82 (Enterprise Value 43.56b / Total Assets 53.07b)
Interest Expense / Debt = 1.11% (Interest Expense 440.0m / Debt 39.62b)
Taxrate = 10.95% (88.3m / 806.4m)
NOPAT = 1.88b (EBIT 2.12b * (1 - 10.95%))
Current Ratio = 0.46 (Total Current Assets 1.85b / Total Current Liabilities 4.00b)
Debt / Equity = 4.70 (Debt 39.62b / totalStockholderEquity, last quarter 8.43b)
Debt / EBITDA = 17.26 (Net Debt 37.78b / EBITDA 2.19b)
Debt / FCF = unknown (Net Debt 37.78b / FCF TTM 0.0)
Total Stockholder Equity = 8.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.37% (Net Income 681.4m / Total Assets 53.07b)
RoE = 8.35% (Net Income TTM 681.4m / Total Stockholder Equity 8.16b)
RoCE = 5.22% (EBIT 2.12b / Capital Employed (Equity 8.16b + L.T.Debt 32.36b))
RoIC = 4.86% (NOPAT 1.88b / Invested Capital 38.75b)
WACC = 1.88% (E(5.78b)/V(45.40b) * Re(8.01%) + D(39.62b)/V(45.40b) * Rd(1.11%) * (1-Tc(0.11)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.10%
[DCF] Fair Price = unknown (Cash Flow 0.0)
EPS Correlation: 78.58 | EPS CAGR: 20.30% | SUE: 3.47 | # QB: 1
Revenue Correlation: 70.83 | Revenue CAGR: 14.93% | SUE: 3.03 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.54 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=2.27 | Chg7d=+0.006 | Chg30d=+0.011 | Revisions Net=-1 | Growth EPS=-3.6% | Growth Revenue=+14.7%
EPS next Year (2027-12-31): EPS=2.31 | Chg7d=+0.007 | Chg30d=-0.045 | Revisions Net=+0 | Growth EPS=+2.1% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.0% (Discount Rate 8.0% - Earnings Yield 10.0%)
[Growth] Growth Spread = +6.0% (Analyst 4.0% - Implied -2.0%)
P/E Forward = 5.0761
P/S = 1.5292
P/B = 0.8787
Revenue TTM = 5.55b USD
EBIT TTM = 2.12b USD
EBITDA TTM = 2.19b USD
Long Term Debt = 32.36b USD (from longTermDebt, two quarters ago)
Short Term Debt = 4.00b USD (from shortTermDebt, last quarter)
Debt = 39.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 37.78b USD (from netDebt column, last quarter)
Enterprise Value = 43.56b USD (5.78b + Debt 39.62b - CCE 1.85b)
Interest Coverage Ratio = 1.22 (Ebit TTM 2.12b / Interest Expense TTM 1.73b)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 43.56b)
FCF Margin = 0.0% (FCF TTM 0.0 / Revenue TTM 5.55b)
Net Margin = 12.27% (Net Income TTM 681.4m / Revenue TTM 5.55b)
Gross Margin = 92.15% ((Revenue TTM 5.55b - Cost of Revenue TTM 435.9m) / Revenue TTM)
Gross Margin QoQ = 90.95% (prev 92.28%)
Tobins Q-Ratio = 0.82 (Enterprise Value 43.56b / Total Assets 53.07b)
Interest Expense / Debt = 1.11% (Interest Expense 440.0m / Debt 39.62b)
Taxrate = 10.95% (88.3m / 806.4m)
NOPAT = 1.88b (EBIT 2.12b * (1 - 10.95%))
Current Ratio = 0.46 (Total Current Assets 1.85b / Total Current Liabilities 4.00b)
Debt / Equity = 4.70 (Debt 39.62b / totalStockholderEquity, last quarter 8.43b)
Debt / EBITDA = 17.26 (Net Debt 37.78b / EBITDA 2.19b)
Debt / FCF = unknown (Net Debt 37.78b / FCF TTM 0.0)
Total Stockholder Equity = 8.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.37% (Net Income 681.4m / Total Assets 53.07b)
RoE = 8.35% (Net Income TTM 681.4m / Total Stockholder Equity 8.16b)
RoCE = 5.22% (EBIT 2.12b / Capital Employed (Equity 8.16b + L.T.Debt 32.36b))
RoIC = 4.86% (NOPAT 1.88b / Invested Capital 38.75b)
WACC = 1.88% (E(5.78b)/V(45.40b) * Re(8.01%) + D(39.62b)/V(45.40b) * Rd(1.11%) * (1-Tc(0.11)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.10%
[DCF] Fair Price = unknown (Cash Flow 0.0)
EPS Correlation: 78.58 | EPS CAGR: 20.30% | SUE: 3.47 | # QB: 1
Revenue Correlation: 70.83 | Revenue CAGR: 14.93% | SUE: 3.03 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.54 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=2.27 | Chg7d=+0.006 | Chg30d=+0.011 | Revisions Net=-1 | Growth EPS=-3.6% | Growth Revenue=+14.7%
EPS next Year (2027-12-31): EPS=2.31 | Chg7d=+0.007 | Chg30d=-0.045 | Revisions Net=+0 | Growth EPS=+2.1% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.0% (Discount Rate 8.0% - Earnings Yield 10.0%)
[Growth] Growth Spread = +6.0% (Analyst 4.0% - Implied -2.0%)